Study: NCT01181310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg
Description: Single doses of placebo to match both donepezil and MK-3134 PO, plus a single dose of scopolamine 0.5 mg SQ.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C: MK-3134 25 mg + Scopolamine 0.5 mg
Description: A single dose of MK-3134 PO 25 mg, plus a single dose of scopolamine SQ 0.5 mg.